- Developed value propositions and crafted strategic plans to identify and engage high-potential clientsthrough comprehensive research, contributing to the achievement of the company's business development goal.- Optimised the client acquisition process by designing an efficient workflow for event preparation,execution, and post-event follow-up, enhancing outcomes for conferences and roundtables.

- Assisted senior investment professionals by developing investment theses and projecting potential returns for early-stage investment deals.- Performed comprehensive evaluations of European healthcare startups to identify and assess high-potential investment opportunities.

- Identified collaboration opportunities in Cambridge’s advanced biopharma ecosystem and established the first international subsidiary of Standigm Inc. from scratch.- Analysed pharmas’ needs to design collaboration scenarios; initiated a collaborative project with global pharma for metabolic disease treatment, marking Standigm’s first major pharma collaboration.- Led two collaborative projects with research labs in the University of Cambridge and Newcastle University regarding drug… Show more - Identified collaboration opportunities in Cambridge’s advanced biopharma ecosystem and established the first international subsidiary of Standigm Inc. from scratch.- Analysed pharmas’ needs to design collaboration scenarios; initiated a collaborative project with global pharma for metabolic disease treatment, marking Standigm’s first major pharma collaboration.- Led two collaborative projects with research labs in the University of Cambridge and Newcastle University regarding drug design utilising AI platforms.- Orchestrated negotiation with Vanderbilt University Medical Centre to secure access to 2.8M patient records by developing synergy ideas between real-world data and AI models; solidified competitivedata advantage.- Headed project with UK-based biopharma to experimentally validate Standigm’s research outcomes;explored strategic alliance opportunities discussing ideas of jointly licensing pipelines. Show less

- Led a team of 10 scientists and engineers to develop Standigm's proprietary drug discovery platform;established technological edge securing $10M funding from a Singaporean investment institution- Partnered with the top 5 pharmaceutical companies and two university labs in South Korea, to solvebespoke drug discovery problems through an AI platform achieving the goals of all parties involved.- Managed collaborations with a top 3 South Korean IT firm, developing natural language… Show more - Led a team of 10 scientists and engineers to develop Standigm's proprietary drug discovery platform;established technological edge securing $10M funding from a Singaporean investment institution- Partnered with the top 5 pharmaceutical companies and two university labs in South Korea, to solvebespoke drug discovery problems through an AI platform achieving the goals of all parties involved.- Managed collaborations with a top 3 South Korean IT firm, developing natural language processingapproach; designed platform structure and oversaw outsourced data preparation team of 7 scientists. Show less